Understanding physicians' attitudes towards hormone therapy

Women's Health Issues

Volumn 15, Issue 1, 2005, Pages 31-38

  Hess, Rachel ^a,b,c   Chang, Chung Chou Joyce ^a   Conigliaro, Joseph ^a,b   McNeil, Melissa ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; FEMALE; HEALTH CARE; HORMONAL THERAPY; HUMAN; INTERNAL MEDICINE; LEARNING; MALE; MENOPAUSE; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; TIME SERIES ANALYSIS;

EID: 12344282782     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2004.10.002     Document Type: Article

References (27)

1. Study of Osteoporotic Fractures Research Group J.A. Cauley, D.G. Seeley, K. Ensrud, B. Ettinger, D. Black, S.R. Cummings Estrogen replacement therapy and fractures in older women Annals of Internal Medicine 122 1 1995 9 16
2. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 350 9084 1997 1047 1059
3. M.H. Davidson, K.C. Maki, P. Marx, A.C. Maki, M.S. Cyrowski, N. Nanavati Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women Archives of Internal Medicine 160 21 2000 3315 3325
4. D. Grady, N.K. Wenger, D. Herrington, S. Khan, C. Furberg, D. Hunninghake Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study Annals of Internal Medicine 132 9 2000 689 696
5. F. Grodstein, J.E. Manson, G.A. Colditz, W.C. Willett, F.E. Speizer, M.J. Stampfer A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease Annals of Internal Medicine 133 12 2000 933 941
6. F. Grodstein, J.E. Manson, M.J. Stampfer Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospectiveobservational study Annals of Internal Medicine 135 1 2001 1 8
7. D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, P.C. Sharp, S.A. Shumaker, T.E. Snyder Effects of estrogen replacement on the progression of coronary-artery atherosclerosis New England Journal of Medicine 343 8 2000 522 529
8. A.L. Hersh, M.L. Stefanick, R.S. Stafford National use of postmenopausal hormone therapy annual trends and response to recent evidence Journal of the American Medical Association 291 1 2004 47 53
9. R. Hess, C.C. Chang, J. Conigliaro, D.M. Elnicki, M. McNeil Experiential learning influences residents knowledge about hormone replacement therapy Teaching and Learning in Medicine 16 3 2004 240 246
10. H.N. Hodis, W.J. Mack, R.A. Lobo, D. Shoupe, A. Sevanian, P.R. Mahrer Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 135 11 2001 939 953
11. Heart and Estrogen/progestin Replacement Study (HERS) Research Group S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women Journal of the American Medical Association 280 7 1998 605 613
12. M.I. Jones, S.M. Greenfield, C.P. Bradley Prescribing new drugs qualitative study of influences on consultants and general practitioners British Medical Journal 323 7309 2001 378 381
13. B.B. McCormick, G. Tomlinson, P. Brill-Edwards, A.S. Detsky Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior Journal of the American Medical Association 286 16 2001 1994 1999
14. S.E. McNagny Prescribing hormone replacement therapy for menopausal symptoms Annals of Internal Medicine 131 8 1999 605 616
15. L. Mosca, P. Collins, D.M. Herrington, M.E. Mendelsohn, R.C. Pasternak, R.M. Robertson Hormone replacement therapy and cardiovascular disease a statement for healthcare professionals from the American Heart Association Circulation 104 4 2001 499 503
16. K.M. Newton, A.Z. LaCroix, D.S. Buist, L.A. Anderson, K. Delaney What factors account for hormone replacement therapy prescribing frequency? Maturitas 39 1 2001 1 10
17. J. Nikolajevic-Sarunac, D.A. Henry, D.L. O'Connell, J. Robertson Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy Journal of General Internal Medicine 14 10 1999 591 598
18. Program Requirements for Residency Education in Internal Medicine 2002 Accreditation Council for Graduate Medical Education Chicago, IL
19. S. Rozenberg, C. Fellemans, H. Ham Opinion survey towards hormone replacement therapy in the prevention of coronary heart disease Maturitas 38 3 2001 273 277
20. C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton, R. Hoover Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk Journal of the American Medical Association 283 4 2000 485 491
21. A. Scuteri, A.J. Bos, L.J. Brant, L. Talbot, E.G. Lakatta, J.L. Fleg Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women Annals of Internal Medicine 135 4 2001 229 238
22. The North American Menopause Society A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women consensus opinion of The North American Menopause Society Menopause 7 2 2000 76 86
23. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial Journal of the American Medical Association 273 3 1995 199 208
24. The Writing Group for the PEPI Trial Effects of hormone therapy on bone mineral density results from the postmenopausal estrogen/progestin interventions (PEPI) trial Journal of the American Medical Association 276 17 1996 1389 1396
25. D.J. Torgerson, S.E. Bell-Syer Hormone replacement therapy and prevention of nonvertebral fractures a meta-analysis of randomized trials Journal of the American Medical Association 285 22 2001 2891 2897
26. Women's Health Initiative Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results From the Women's Health Initiative randomized controlled trial Journal of the American Medical Association 288 3 2002 321 333
27. C.M. Viscoli, L.M. Brass, W.N. Kernan, P.M. Sarrel, S. Suissa, R.I. Horwitz A clinical trial of estrogen-replacement therapy after ischemic stroke New England Journal of Medicine 345 17 2001 1243 1249